Biotech

All Articles

Boehringer offers up to $1.3 B for checkpoint prevention biotech

.Boehringer Ingelheim is offering up to $1.3 billion for Nerio Therapeutics and a preclinical invuln...

Ventyx's last hope for inflamed med ends in Crohn's failing

.Ventyx Biosciences' Crohn's disease medicine carried out certainly not assist individuals achieve r...

Cognition's phase 2 beam records taint Alzheimer's prospect

.Knowledge Rehabs' phase 2 SHINE test has actually taken a few of the luster off the Alzheimer's con...

BMS axes bispecific months after submitting to function stage 3 trial

.Bristol Myers Squibb has actually had a whiplash change of heart on its own BCMA bispecific T-cell ...

Charles Baum manages Terremoto as CEO

.Charles Baum, M.D., Ph.D., who looked after Mirati Therapies' $ 5.8 billion purchase to Bristol Mye...

Asarina to shut after attempts to partner Tourette's drug fail

.After connecting to much more than 200 companies to partner a Tourette disorder treatment that reve...

Novartis markers $150M upfront bispecifics manage Dren Bio

.Novartis has possessed some rotten luck with bispecific antibodies before, but evaluating due to th...

AstraZeneca vegetations an EGFR plant with Pinetree offer worth $45M

.Pinetree Rehabs are going to assist AstraZeneca vegetation some trees in its own pipe with a new tr...

GRO collects $60M series B to take gout arthritis treatment into medical clinic

.GRO Biosciences has actually ended the full week with an added $60.3 thousand in the financial inst...

Chutes &amp Ladders-- Gilead's Merdad Parsey goes, Cassava drops chief executive officer

.Accept to this week's Chutes &amp Ladders, our roundup of substantial leadership hirings, firings a...